Sonoclear

SonoClear is a private, clinical-stage medical device company developing a novel ultrasound couplant to address a critical unmet need in neurosurgery. Its core product, the SonoClear System, is designed to eliminate imaging artifacts common when using saline, thereby improving diagnostic accuracy and potentially enabling more complete tumor resections with fewer complications. The company is rooted in Norway's leading ultrasound research cluster, has completed Phase 1 of a pivotal multi-center trial, and is led by a management team with commercial and healthcare expertise. SonoClear operates in the high-value intersection of oncology and surgical guidance, targeting a clear improvement in a standard-of-care procedural step.

Precision-engineered acoustic couplant fluid designed to match the ultrasound signature of healthy brain tissue, eliminating enhancement artifacts in intraoperative ultrasound imaging.

SonoClear's direct competition is the current standard of care: saline and lactated ringers used as free, ubiquitous couplants. Indirect competition includes other intraoperative imaging modalities like MRI-guided systems (e.g., Medtronic's StealthStation, Brainlab) and advanced ultrasound software enhancements. SonoClear's unique position is as a consumable that upgrades the performance of all existing ultrasound hardware without replacement, a potentially disruptive and cost-effective approach.